Richard E. Royal
- Oncology top 0.1%
- Immunology top 0.2%
- Molecular Biology top 5%
- Genetics top 1%
- Surgery top 2%
- Co-authors
- Steven A. RosenbergRichard M. SherryUdai S. KammulaMarybeth S. HughesJames Chih‐Hsin YangSuzanne L. TopalianCatherine LévySharon Mavroukakis
- Topics
- Intraperitoneal and Appendiceal Malignancies (33 papers)Immunotherapy and Immune Responses (23 papers)Cancer Immunotherapy and Biomarkers (21 papers)
- Partner nations
- United StatesAustraliaNetherlands
In The Last Decade
Richard E. Royal
97 papers receiving 10.9k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Oncology 8.1k
- Immunology 5.7k
- Molecular Biology 2.3k
- Genetics 1.4k
- Surgery 1.3k
Countries citing papers authored by Richard E. Royal
This map shows the geographic impact of Richard E. Royal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard E. Royal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard E. Royal more than expected).
Fields of papers citing papers by Richard E. Royal
This network shows the impact of papers produced by Richard E. Royal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard E. Royal. The network helps show where Richard E. Royal may publish in the future.
Co-authorship network of co-authors of Richard E. Royal
This figure shows the co-authorship network connecting the top 25 collaborators of Richard E. Royal. A scholar is included among the top collaborators of Richard E. Royal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard E. Royal. Richard E. Royal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 52 | |
| 2 | 0 | |
| 3 | 4 | |
| 4 | 10 | |
| 5 | 5 | |
| 6 | 4 | |
| 7 | 105 | |
| 8 | 37 | |
| 9 | 84 | |
| 10 | 28 | |
| 11 | Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimensbreakdown → | 1017 |
| 12 | Ipilimumab (Anti-CTLA4 Antibody) Causes Regression of Metastatic Renal Cell Cancer Associated With Enteritis and Hypophysitisbreakdown → | 537 |
| 13 | Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytesbreakdown → | 1961 |
| 14 | Enterocolitis in Patients With Cancer After Antibody Blockade of Cytotoxic T-Lymphocyte–Associated Antigen 4breakdown → | 646 |
| 15 | 28 | |
| 16 | 214 | |
| 17 | 365 | |
| 18 | 42 | |
| 19 | 9 | |
| 20 | 39 |
About Richard E. Royal
Richard E. Royal is a scholar working on Reproductive Medicine, Oncology and Emergency Medicine, having authored 100 papers that have together received 11.1k indexed citations. Recurring topics across this work include Intraperitoneal and Appendiceal Malignancies (33 papers), Immunotherapy and Immune Responses (23 papers) and Cancer Immunotherapy and Biomarkers (21 papers). The work is most often cited by research in Oncology (8.1k citations), Immunology (5.7k citations) and Reproductive Medicine (435 citations). Richard E. Royal has collaborated with scholars based in United States, Australia and Netherlands. Frequent co-authors include Steven A. Rosenberg, Richard M. Sherry, Udai S. Kammula, Marybeth S. Hughes, James Chih‐Hsin Yang, Suzanne L. Topalian, Catherine Lévy, Sharon Mavroukakis, Nicholas P. Restifo and Donald E. White. Their work appears in journals such as Science, Nature Medicine and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.